UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 252

Sortiert nach

Potential Roles of Redox Dysregulation in the Development of Schizophrenia

Biological psychiatry (1969), 2020-08, Vol.88 (4), p.326-336

2020

Link zum Volltext

Verfügbarkeit prüfen

Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis

The American journal of psychiatry, 2005-10, Vol.162 (10), p.1785-1804

2005

Link zum Volltext

Verfügbarkeit prüfen

Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project

Schizophrenia bulletin, 2015-03, Vol.41 (2), p.419-428

2015

Link zum Volltext

Verfügbarkeit prüfen

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis

Schizophrenia bulletin, 2016-05, Vol.42 (3), p.732-743

2016

Link zum Volltext

Verfügbarkeit prüfen

Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk

The American journal of psychiatry, 2020-02, Vol.177 (2), p.155-163

2020

Link zum Volltext

Verfügbarkeit prüfen

At Clinical High Risk for Psychosis: Outcome for Nonconverters

The American journal of psychiatry, 2011-08, Vol.168 (8), p.800-805

2011

Link zum Volltext

Verfügbarkeit prüfen

Nuclear and cytoplasmic localization of neural stem cell microRNAs

RNA (Cambridge), 2011-04, Vol.17 (4), p.675-686

2011

Link zum Volltext

Verfügbarkeit prüfen

Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study

Biological psychiatry (1969), 2013-09, Vol.74 (6), p.410-417

2013

Link zum Volltext

Verfügbarkeit prüfen

Negative symptoms in individuals at clinical high risk of psychosis

Psychiatry research, 2012-04, Vol.196 (2), p.220-224

2012

Link zum Volltext

Verfügbarkeit prüfen

Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study

Schizophrenia bulletin, 2009-09, Vol.35 (5), p.894-908

2009

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)

The American journal of psychiatry, 2011-09, Vol.168 (9), p.947-956

2011

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

The American journal of psychiatry, 2007-07, Vol.164 (7), p.1050-1060

2007

Link zum Volltext

Verfügbarkeit prüfen

Premorbid functional development and conversion to psychosis in clinical high-risk youths

Development and psychopathology, 2013-11, Vol.25 (4pt1), p.1171-1186

2013

Link zum Volltext

Verfügbarkeit prüfen

A greedy regression algorithm with coarse weights offers novel advantages

Scientific reports, 2022-03, Vol.12 (1), p.5440-5440, Article 5440

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

The American journal of psychiatry, 2007-07, Vol.164 (7), p.1061-1071

2007

Link zum Volltext

Verfügbarkeit prüfen

Implications for the Neural Basis of Social Cognition for the Study of Schizophrenia

The American journal of psychiatry, 2003-05, Vol.160 (5), p.815-824

2003

Link zum Volltext

Verfügbarkeit prüfen

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis

Frontiers in psychiatry, 2023-05, Vol.14, p.1125168-1125168

2023

Link zum Volltext

Verfügbarkeit prüfen

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2011-02, Vol.36 (3), p.616-626

2011

Link zum Volltext

Verfügbarkeit prüfen

Hippocampal Connectivity With the Default Mode Network Is Linked to Hippocampal Volume in the Clinical High Risk for Psychosis Syndrome and Healthy Individuals

Clinical psychological science, 2023-09, Vol.11 (5), p.801-818

2023

Link zum Volltext

Verfügbarkeit prüfen

Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms

Early intervention in psychiatry, 2021-08, Vol.15 (4), p.818-827

2021

Link zum Volltext

Verfügbarkeit prüfen

Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis

Frontiers in psychiatry, 2023-04, Vol.14, p.1143315-1143315

2023

Link zum Volltext

Verfügbarkeit prüfen

The Role of microRNA Expression in Cortical Development During Conversion to Psychosis

Neuropsychopharmacology (New York, N.Y.), 2017-10, Vol.42 (11), p.2188-2195

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictors of noncompliance in patients with schizophrenia

The journal of clinical psychiatry, 2002-12, Vol.63 (12), p.1121

Perkins, Diana O

2002

Link zum Volltext

Verfügbarkeit prüfen

Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

The journal of clinical psychiatry, 2017-11, Vol.78 (9), p.e1431

Perkins, Diana O

2017

Link zum Volltext

Verfügbarkeit prüfen

Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis

NeuroImage clinical, 2021-01, Vol.31, p.102757-102757, Article 102757

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 252

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieSchizophrenia Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(225)

Publikationsform

Sprache

Englisch
(252)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

Humans
(174)
Science & Technology
(171)
Life Sciences & Biomedicine
(167)
Psychiatry
(147)
Male
(121)
Female
(109)
Schizophrenia
(96)
Adult
(95)
Psychosis
(90)
Adolescent
(78)
Biological And Medical Sciences
(70)
Medical Sciences
(65)
Psychology. Psychoanalysis. Psychiatry
(62)
Longitudinal Studies
(60)
Young Adult
(56)
Prodromal Symptoms
(52)
Psychopathology. Psychiatry
(52)
Psychotic Disorders - Diagnosis
(44)
Risk Factors
(44)
Psychotic Disorders - Psychology
(43)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Potential Roles of Redox Dysregulation in the Development of Schizophrenia

Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis

Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis

Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk

At Clinical High Risk for Psychosis: Outcome for Nonconverters

Nuclear and cytoplasmic localization of neural stem cell microRNAs

Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study

Negative symptoms in individuals at clinical high risk of psychosis

Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study

A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)

Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

Premorbid functional development and conversion to psychosis in clinical high-risk youths

A greedy regression algorithm with coarse weights offers novel advantages

Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

Implications for the Neural Basis of Social Cognition for the Study of Schizophrenia

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia

Hippocampal Connectivity With the Default Mode Network Is Linked to Hippocampal Volume in the Clinical High Risk for Psychosis Syndrome and Healthy Individuals

Associations between childhood adversity, cognitive schemas and attenuated psychotic symptoms

Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis

The Role of microRNA Expression in Cortical Development During Conversion to Psychosis

Predictors of noncompliance in patients with schizophrenia

Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?

Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis

Aktive Filter

Suchergebnisse filtern